(DOC) Healthpeak Properties - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US42250P1030

Outpatient Medical, Lab, CCRC, Joint Venture Loans

Stock: Health Care REITs
Age 38.2y
MCap 12,391m
Avg Vol 8.00M (134M USD)
Beta 0.451
Volatility 23.03%

EPS (Earnings per Share)

EPS (Earnings per Share) of DOC over the last years for every Quarter: "2020-12": 0.1, "2021-03": 0.08, "2021-06": 0.08, "2021-09": 0.1, "2021-12": 0.12, "2022-03": 0.06, "2022-06": 0.07, "2022-09": 0.28, "2022-12": 0.05, "2023-03": 0.04, "2023-06": 0.05, "2023-09": 0.05, "2023-12": 0.05, "2024-03": 0.01, "2024-06": 0.21, "2024-09": 0.05, "2024-12": 0.05, "2025-03": 0.06, "2025-06": 0.06, "2025-09": -0.1819, "2025-12": 0,
EPS CAGR: -7.16%
EPS Trend: -44.1%
Last SUE: -0.69
Qual. Beats: 0

Revenue

Revenue of DOC over the last years for every Quarter: 2020-12: -126.454, 2021-03: 455.276, 2021-06: 476.238, 2021-09: 481.465, 2021-12: 483.205, 2022-03: 498.372, 2022-06: 517.932, 2022-09: 520.406, 2022-12: 524.468, 2023-03: 525.678, 2023-06: 545.43, 2023-09: 556.243, 2023-12: 553.652, 2024-03: 606.56, 2024-06: 695.504, 2024-09: 700.397, 2024-12: 697.988, 2025-03: 702.889, 2025-06: 694.348, 2025-09: 705.873, 2025-12: null,
Rev. CAGR: 10.63%
Rev. Trend: 95.2%
Last SUE: 2.35
Qual. Beats: 1

Dividends

Dividend Yield 7.34%
Yield on Cost 5y 7.39%
Yield CAGR 5y -12.85%
Payout Consistency 96.7%
Payout Ratio 504.2%
Risk via 5d forecast
Volatility 23.0%
Value at Risk 5%th 36.7%
Relative Tail Risk -3.07%
Reward TTM
Sharpe Ratio -0.39
Alpha -16.75
CAGR/Max DD -0.15
Character TTM
Hurst Exponent 0.557
Beta 0.451
Beta Downside 0.646
Drawdowns 3y
Max DD 40.71%
Mean DD 20.90%
Median DD 21.97%

Description: DOC Healthpeak Properties January 03, 2026

Healthpeak Properties, Inc. (NYSE: DOC) is an S&P 500-listed REIT that owns, operates, and develops a diversified portfolio of U.S. healthcare real estate across three core segments: outpatient medical facilities, laboratory spaces, and continuing-care retirement communities (CCRCs). Structured as an umbrella partnership REIT (UPREIT), the company holds the vast majority of its assets through its operating subsidiary, Healthpeak OP, and reports a total of 703 property interests as of September 30 2025, including 530 outpatient, 139 lab, 15 CCRC, and 19 non-reportable assets.

Key performance indicators from the most recent fiscal year show a funds-from-operations (FFO) of approximately $1.10 per share and an occupancy rate near 96% across the portfolio, reflecting strong demand for outpatient and lab space. The REIT’s leverage ratio remains around 45% of total assets, a level that analysts consider moderate given the sector’s sensitivity to interest-rate movements. Demographic trends-particularly the aging U.S. population and the shift toward outpatient care-continue to drive demand for Healthpeak’s property types, while the company’s dividend yield hovers near 5.5%.

For a deeper dive into Healthpeak’s valuation metrics, you might explore the detailed analyst toolkit on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-38.1m TTM) > 0 and > 6% of Revenue (6% = 168.1m TTM)
FCFTA 0.06 (>2.0%) and ΔFCFTA 1.24pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -5.18% (prev -26.16%; Δ 20.98pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.06 (>3.0%) and CFO 1.24b > Net Income -38.1m (YES >=105%, WARN >=100%)
Net Debt (9.34b) to EBITDA (1.52b) ratio: 6.14 <= 3.0 (WARN <= 3.5)
Current Ratio 0.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (696.4m) change vs 12m ago -0.54% (target <= -2.0% for YES)
Gross Margin 60.08% (prev 60.01%; Δ 0.07pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 14.16% (prev 12.80%; Δ 1.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.53 (EBITDA TTM 1.52b / Interest Expense TTM 295.0m) >= 6 (WARN >= 3)

Altman Z'' -1.35

(A) -0.01 = (Total Current Assets 981.7m - Total Current Liabilities 1.13b) / Total Assets 19.58b
(B) -0.30 = Retained Earnings (Balance) -5.85b / Total Assets 19.58b
(C) 0.02 = EBIT TTM 451.0m / Avg Total Assets 19.78b
(D) -0.46 = Book Value of Equity -5.17b / Total Liabilities 11.32b
Total Rating: -1.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 59.95

1. Piotroski 3.0pt
2. FCF Yield 5.71%
3. FCF Margin 44.32%
4. Debt/Equity 1.24
5. Debt/Ebitda 6.14
6. ROIC - WACC (= -2.03)%
7. RoE -0.47%
8. Rev. Trend 95.18%
9. EPS Trend -44.06%

What is the price of DOC shares?

As of January 21, 2026, the stock is trading at USD 17.83 with a total of 6,485,886 shares traded.
Over the past week, the price has changed by +5.87%, over one month by +11.81%, over three months by -3.03% and over the past year by -9.18%.

Is DOC a buy, sell or hold?

Healthpeak Properties has received a consensus analysts rating of 4.25. Therefore, it is recommended to buy DOC.
  • Strong Buy: 10
  • Buy: 5
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the DOC price?

Issuer Target Up/Down from current
Wallstreet Target Price 20.3 13.9%
Analysts Target Price 20.3 13.9%
ValueRay Target Price 18.5 3.5%

DOC Fundamental Data Overview January 21, 2026

P/E Forward = 71.4286
P/S = 4.4236
P/B = 1.631
P/EG = 4.0809
Revenue TTM = 2.80b USD
EBIT TTM = 451.0m USD
EBITDA TTM = 1.52b USD
Long Term Debt = 8.76b USD (from longTermDebt, last quarter)
Short Term Debt = 368.1m USD (from shortTermDebt, last quarter)
Debt = 9.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.34b USD (from netDebt column, last quarter)
Enterprise Value = 21.73b USD (12.39b + Debt 9.43b - CCE 91.0m)
Interest Coverage Ratio = 1.53 (Ebit TTM 451.0m / Interest Expense TTM 295.0m)
EV/FCF = 17.51x (Enterprise Value 21.73b / FCF TTM 1.24b)
FCF Yield = 5.71% (FCF TTM 1.24b / Enterprise Value 21.73b)
FCF Margin = 44.32% (FCF TTM 1.24b / Revenue TTM 2.80b)
Net Margin = -1.36% (Net Income TTM -38.1m / Revenue TTM 2.80b)
Gross Margin = 60.08% ((Revenue TTM 2.80b - Cost of Revenue TTM 1.12b) / Revenue TTM)
Gross Margin QoQ = 58.64% (prev 60.22%)
Tobins Q-Ratio = 1.11 (Enterprise Value 21.73b / Total Assets 19.58b)
Interest Expense / Debt = 0.81% (Interest Expense 76.8m / Debt 9.43b)
Taxrate = 1.60% (4.35m / 271.7m)
NOPAT = 443.8m (EBIT 451.0m * (1 - 1.60%))
Current Ratio = 0.87 (Total Current Assets 981.7m / Total Current Liabilities 1.13b)
Debt / Equity = 1.24 (Debt 9.43b / totalStockholderEquity, last quarter 7.60b)
Debt / EBITDA = 6.14 (Net Debt 9.34b / EBITDA 1.52b)
Debt / FCF = 7.53 (Net Debt 9.34b / FCF TTM 1.24b)
Total Stockholder Equity = 8.03b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.19% (Net Income -38.1m / Total Assets 19.58b)
RoE = -0.47% (Net Income TTM -38.1m / Total Stockholder Equity 8.03b)
RoCE = 2.69% (EBIT 451.0m / Capital Employed (Equity 8.03b + L.T.Debt 8.76b))
RoIC = 2.62% (NOPAT 443.8m / Invested Capital 16.97b)
WACC = 4.65% (E(12.39b)/V(21.82b) * Re(7.58%) + D(9.43b)/V(21.82b) * Rd(0.81%) * (1-Tc(0.02)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 12.79%
[DCF Debug] Terminal Value 87.31% ; FCFF base≈1.15b ; Y1≈1.28b ; Y5≈1.67b
Fair Price DCF = 57.41 (EV 49.24b - Net Debt 9.34b = Equity 39.90b / Shares 694.9m; r=5.90% [WACC]; 5y FCF grow 12.72% → 2.90% )
EPS Correlation: -44.06 | EPS CAGR: -7.16% | SUE: -0.69 | # QB: 0
Revenue Correlation: 95.18 | Revenue CAGR: 10.63% | SUE: 2.35 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.09 | Chg30d=+0.014 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=0.25 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+2600.0% | Growth Revenue=+1.7%

Additional Sources for DOC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle